{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:05:58Z","timestamp":1793156758710,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T00:00:00Z","timestamp":1541462400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RC 21-2015"],"award-info":[{"award-number":["RC 21-2015"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12876-018-0888-6","type":"journal-article","created":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T04:38:45Z","timestamp":1541479125000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":95,"title":["Noninvasive biomarkers of gut barrier function identify two subtypes of patients suffering from diarrhoea predominant-IBS: a case-control study"],"prefix":"10.1186","volume":"18","author":[{"given":"Michele","family":"Linsalata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Riezzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"D\u2019Attoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Clemente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Orlando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0538-6072","authenticated-orcid":false,"given":"Francesco","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,6]]},"reference":[{"issue":"4","key":"888_CR1","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ejim.2010.05.009","volume":"21","author":"P Usai","year":"2010","unstructured":"Usai P, Manca R, Lai MA, Russo L, Boi MF, Ibba I, Giolitto G, Cuomo R. Prevalence of irritable bowel syndrome in Italian rural and urban areas. Eur J Intern Med. 2010;21(4):324\u20136.","journal-title":"Eur J Intern Med"},{"issue":"3","key":"888_CR2","first-page":"237","volume":"15","author":"DA Drossman","year":"2006","unstructured":"Drossman DA, Dumitrascu DL, Rome III. New standard for functional gastrointestinal disorders. J Gastrointestin Liver Dis. 2006;15(3):237\u201341.","journal-title":"J Gastrointestin Liver Dis"},{"issue":"2","key":"888_CR3","first-page":"57","volume":"108","author":"F Mearin","year":"2016","unstructured":"Mearin F. Irritable bowel syndrome (IBS) subtypes: nothing resembles less an IBS than another IBS. Rev Esp Enferm Dig. 2016;108(2):57\u20138.","journal-title":"Rev Esp Enferm Dig"},{"issue":"7","key":"888_CR4","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/apt.13746","volume":"44","author":"MR Blake","year":"2016","unstructured":"Blake MR, Raker JM, Whelan K. Validity and reliability of the Bristol stool form scale in healthy adults and patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2016;44(7):693\u2013703.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"888_CR5","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1046\/j.1365-2036.2003.01666.x","volume":"18","author":"B Shahbazkhani","year":"2003","unstructured":"Shahbazkhani B, Forootan M, Merat S, Akbari MR, Nasserimoghadam S, Vahedi H, Malekzadeh R. Coeliac disease presenting with symptoms of irritable bowel syndrome. Aliment Pharmacol Ther. 2003;18(2):231\u20135.","journal-title":"Aliment Pharmacol Ther"},{"issue":"10115","key":"888_CR6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/S0140-6736(17)31796-8","volume":"391","author":"B Lebwohl","year":"2018","unstructured":"Lebwohl B, Sanders DS, Green PHR. Coeliac disease. Lancet. 2018;391(10115):70\u201381.","journal-title":"Lancet"},{"issue":"9","key":"888_CR7","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1136\/gutjnl-2011-300327","volume":"61","author":"M Heyman","year":"2012","unstructured":"Heyman M, Abed J, Lebreton C, Cerf-Bensussan N. Intestinal permeability in coeliac disease: insight into mechanisms and relevance to pathogenesis. Gut. 2012;61(9):1355\u201364.","journal-title":"Gut"},{"issue":"1","key":"888_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/jgh.13417","volume":"32","author":"AM Gonzalez-Castro","year":"2017","unstructured":"Gonzalez-Castro AM, Martinez C, Salvo-Romero E, Fortea M, Pardo-Camacho C, Perez-Berezo T, Alonso-Cotoner C, Santos J, Vicario M. Mucosal pathobiology and molecular signature of epithelial barrier dysfunction in the small intestine in irritable bowel syndrome. J Gastroenterol Hepatol. 2017;32(1):53\u201363.","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"888_CR9","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jcmgh.2016.12.006","volume":"3","author":"M Schumann","year":"2017","unstructured":"Schumann M, Siegmund B, Schulzke JD, Fromm M. Celiac disease: role of the epithelial barrier. Cell Mol Gastroenterol Hepatol. 2017;3(2):150\u201362.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"3","key":"888_CR10","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/nmo.12315","volume":"26","author":"T Piche","year":"2014","unstructured":"Piche T. Tight junctions and IBS--the link between epithelial permeability, low-grade inflammation, and symptom generation? Neurogastroenterol Motil. 2014;26(3):296\u2013302.","journal-title":"Neurogastroenterol Motil"},{"issue":"6","key":"888_CR11","first-page":"1068","volume":"19","author":"LR Lopetuso","year":"2015","unstructured":"Lopetuso LR, Scaldaferri F, Bruno G, Petito V, Franceschi F, Gasbarrini A. The therapeutic management of gut barrier leaking: the emerging role for mucosal barrier protectors. Eur Rev Med Pharmacol Sci. 2015;19(6):1068\u201376.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"888_CR12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2147\/CEG.S31799","volume":"5","author":"K van Wijck","year":"2012","unstructured":"van Wijck K, Bessems BA, van Eijk HM, Buurman WA, Dejong CH, Lenaerts K. Polyethylene glycol versus dual sugar assay for gastrointestinal permeability analysis: is it time to choose? Clin Exp Gastroenterol. 2012;5:139\u201350.","journal-title":"Clin Exp Gastroenterol"},{"key":"888_CR13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12876-014-0189-7","volume":"14","author":"S Bischoff","year":"2014","unstructured":"Bischoff S, Bischoff SC, Barbara G, Buurman W, Ockhuizen T, Schulzke JD, Serino M, Tilg H, Watson A, Wells JM. Intestinal permeability - a new target for disease prevention and therapy. BMC Gastroenterol. 2014;14:189.","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"888_CR14","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.clnu.2012.06.014","volume":"32","author":"K van Wijck","year":"2013","unstructured":"van Wijck K, Verlinden TJ, van Eijk HM, Dekker J, Buurman WA, Dejong CH, Lenaerts K. Novel multi-sugar assay for site-specific gastrointestinal permeability analysis: a randomized controlled crossover trial. Clin Nutr. 2013;32(2):245\u201351.","journal-title":"Clin Nutr"},{"key":"888_CR15","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.2147\/TCRM.S115902","volume":"12","author":"JM Aguirre Valadez","year":"2016","unstructured":"Aguirre Valadez JM, Rivera-Espinosa L, Mendez-Guerrero O, Chavez-Pacheco JL, Garcia Juarez I, Torre A. Intestinal permeability in a patient with liver cirrhosis. Ther Clin Risk Manag. 2016;12:1729\u201348.","journal-title":"Ther Clin Risk Manag"},{"issue":"4","key":"888_CR16","doi-asserted-by":"publisher","first-page":"e1251384","DOI":"10.1080\/21688370.2016.1251384","volume":"4","author":"C Sturgeon","year":"2016","unstructured":"Sturgeon C, Fasano A. Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases. Tissue Barriers. 2016;4(4):e1251384.","journal-title":"Tissue Barriers"},{"issue":"1\u20132","key":"888_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cccn.2004.09.001","volume":"352","author":"MM Pelsers","year":"2005","unstructured":"Pelsers MM, Hermens WT, Glatz JF. Fatty acid-binding proteins as plasma markers of tissue injury. Clin Chim Acta. 2005;352(1\u20132):15\u201335.","journal-title":"Clin Chim Acta"},{"issue":"2","key":"888_CR18","doi-asserted-by":"publisher","first-page":"E23","DOI":"10.1002\/ibd.21588","volume":"17","author":"Y Honzawa","year":"2011","unstructured":"Honzawa Y, Nakase H, Matsuura M, Chiba T. Clinical significance of serum diamine oxidase activity in inflammatory bowel disease: importance of evaluation of small intestinal permeability. Inflamm Bowel Dis. 2011;17(2):E23\u20135.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"888_CR19","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/apt.13848","volume":"45","author":"XJ Xu","year":"2017","unstructured":"Xu XJ, Zhang YL, Liu L, Pan L, Yao SK. Increased expression of nerve growth factor correlates with visceral hypersensitivity and impaired gut barrier function in diarrhoea-predominant irritable bowel syndrome: a preliminary explorative study. Aliment Pharmacol Ther. 2017;45(1):100\u201314.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"888_CR20","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/BF01535722","volume":"33","author":"J Svedlund","year":"1988","unstructured":"Svedlund J, Sjodin I, Dotevall G. GSRS--a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci. 1988;33(2):129\u201334.","journal-title":"Dig Dis Sci"},{"issue":"10","key":"888_CR21","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1111\/j.1572-0241.1999.01440.x","volume":"94","author":"M Schmulson","year":"1999","unstructured":"Schmulson M, Lee OY, Chang L, Naliboff B, Mayer EA. Symptom differences in moderate to severe IBS patients based on predominant bowel habit. Am J Gastroenterol. 1999;94(10):2929\u201335.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"888_CR22","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1038\/ajg.2009.188","volume":"104","author":"EF Verdu","year":"2009","unstructured":"Verdu EF, Armstrong D, Murray JA. Between celiac disease and irritable bowel syndrome: the \u201cno man\u2019s land\u201d of gluten sensitivity. Am J Gastroenterol. 2009;104(6):1587\u201394.","journal-title":"Am J Gastroenterol"},{"key":"888_CR23","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12937-015-0080-6","volume":"14","author":"M El-Salhy","year":"2015","unstructured":"El-Salhy M, Hatlebakk JG, Gilja OH, Hausken T. The relation between celiac disease, nonceliac gluten sensitivity and irritable bowel syndrome. Nutr J. 2015;14:92.","journal-title":"Nutr J"},{"issue":"4","key":"888_CR24","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/01.MP.0000062997.16339.47","volume":"16","author":"DA Antonioli","year":"2003","unstructured":"Antonioli DA. Celiac disease: a progress report. Mod Pathol. 2003;16(4):342\u20136.","journal-title":"Mod Pathol"},{"key":"888_CR25","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1471-2407-13-56","volume":"13","author":"F Russo","year":"2013","unstructured":"Russo F, Linsalata M, Clemente C, D'Attoma B, Orlando A, Campanella G, Giotta F, Riezzo G. The effects of fluorouracil, epirubicin, and cyclophosphamide (FEC60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study. BMC Cancer. 2013;13:56.","journal-title":"BMC Cancer"},{"issue":"4","key":"888_CR26","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1515\/cclm-2013-0468","volume":"52","author":"M Linsalata","year":"2014","unstructured":"Linsalata M, D'Attoma B, Orlando A, Guerra V, Russo F. Comparison of an enzymatic assay with liquid chromatography-pulsed amperometric detection for the determination of lactulose and mannitol in the urine of healthy subjects and patients with active celiac disease. Clin Chem Lab Med. 2014;52(4):e61\u20134.","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"888_CR27","doi-asserted-by":"publisher","first-page":"305","DOI":"10.5009\/gnl.2012.6.3.305","volume":"6","author":"C Martinez","year":"2012","unstructured":"Martinez C, Gonzalez-Castro A, Vicario M, Santos J. Cellular and molecular basis of intestinal barrier dysfunction in the irritable bowel syndrome. Gut Liver. 2012;6(3):305\u201315.","journal-title":"Gut Liver"},{"issue":"3","key":"888_CR28","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/apt.12829","volume":"40","author":"Z Mujagic","year":"2014","unstructured":"Mujagic Z, Ludidi S, Keszthelyi D, Hesselink MA, Kruimel JW, Lenaerts K, Hanssen NM, Conchillo JM, Jonkers DM, Masclee AA. Small intestinal permeability is increased in diarrhoea predominant IBS, while alterations in gastroduodenal permeability in all IBS subtypes are largely attributable to confounders. Aliment Pharmacol Ther. 2014;40(3):288\u201397.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"888_CR29","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/MCG.0000000000000531","volume":"51","author":"F Russo","year":"2017","unstructured":"Russo F, Chimienti G, Clemente C, Riezzo G, D'Attoma B, Martulli M. Gastric activity and gut peptides in patients with functional dyspepsia: postprandial distress syndrome versus epigastric pain syndrome. J Clin Gastroenterol. 2017;51(2):136\u201344.","journal-title":"J Clin Gastroenterol"},{"issue":"6","key":"888_CR30","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1159\/000016886","volume":"16","author":"H Vogelsang","year":"1998","unstructured":"Vogelsang H, Schwarzenhofer M, Oberhuber G. Changes in gastrointestinal permeability in celiac disease. Dig Dis. 1998;16(6):333\u20136.","journal-title":"Dig Dis"},{"issue":"2","key":"888_CR31","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s10620-016-4403-z","volume":"62","author":"T Vorobjova","year":"2017","unstructured":"Vorobjova T, Raikkerus H, Kadaja L, Talja I, Uibo O, Heilman K, Uibo R. Circulating Zonulin correlates with density of enteroviruses and Tolerogenic dendritic cells in the small bowel mucosa of celiac disease patients. Dig Dis Sci. 2017;62(2):358\u201371.","journal-title":"Dig Dis Sci"},{"key":"888_CR32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.cca.2012.12.032","volume":"418","author":"AY Del Valle-Pinero","year":"2013","unstructured":"Del Valle-Pinero AY, Van Deventer HE, Fourie NH, Martino AC, Patel NS, Remaley AT, Henderson WA. Gastrointestinal permeability in patients with irritable bowel syndrome assessed using a four probe permeability solution. Clin Chim Acta. 2013;418:97\u2013101.","journal-title":"Clin Chim Acta"},{"issue":"3","key":"888_CR33","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1007\/s10620-009-0765-9","volume":"55","author":"AP Kerckhoffs","year":"2010","unstructured":"Kerckhoffs AP, Akkermans LM, de Smet MB, Besselink MG, Hietbrink F, Bartelink IH, Busschers WB, Samsom M, Renooij W. Intestinal permeability in irritable bowel syndrome patients: effects of NSAIDs. Dig Dis Sci. 2010;55(3):716\u201323.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"888_CR34","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1159\/000333083","volume":"85","author":"K Gecse","year":"2012","unstructured":"Gecse K, Roka R, Sera T, Rosztoczy A, Annahazi A, Izbeki F, Nagy F, Molnar T, Szepes Z, Pavics L, et al. Leaky gut in patients with diarrhea-predominant irritable bowel syndrome and inactive ulcerative colitis. Digestion. 2012;85(1):40\u20136.","journal-title":"Digestion"},{"issue":"5","key":"888_CR35","doi-asserted-by":"publisher","first-page":"G919","DOI":"10.1152\/ajpgi.00168.2011","volume":"301","author":"AS Rao","year":"2011","unstructured":"Rao AS, Camilleri M, Eckert DJ, Busciglio I, Burton DD, Ryks M, Wong BS, Lamsam J, Singh R, Zinsmeister AR. Urine sugars for in vivo gut permeability: validation and comparisons in irritable bowel syndrome-diarrhea and controls. Am J Physiol Gastrointest Liver Physiol. 2011;301(5):G919\u201328.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"6","key":"888_CR36","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1111\/j.1572-0241.2006.00672.x","volume":"101","author":"SP Dunlop","year":"2006","unstructured":"Dunlop SP, Hebden J, Campbell E, Naesdal J, Olbe L, Perkins AC, Spiller RC. Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes. Am J Gastroenterol. 2006;101(6):1288\u201394.","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"888_CR37","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.dld.2016.05.002","volume":"48","author":"L Li","year":"2016","unstructured":"Li L, Xiong L, Yao J, Zhuang X, Zhang S, Yu Q, Xiao Y, Cui Y, Chen M. Increased small intestinal permeability and RNA expression profiles of mucosa from terminal ileum in patients with diarrhoea-predominant irritable bowel syndrome. Dig Liver Dis. 2016;48(8):880\u20137.","journal-title":"Dig Liver Dis"},{"issue":"3","key":"888_CR38","doi-asserted-by":"publisher","first-page":"582","DOI":"10.3390\/ijms18030582","volume":"18","author":"Bodil Ohlsson","year":"2017","unstructured":"Ohlsson B, Orho-Melander M, Nilsson PM. Higher levels of serum Zonulin may rather be associated with increased risk of obesity and hyperlipidemia, than with gastrointestinal symptoms or disease manifestations. Int J Mol Sci. 2017;18(3):582.","journal-title":"International Journal of Molecular Sciences"},{"issue":"1\u20132","key":"888_CR39","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.pain.2009.06.017","volume":"146","author":"Q Zhou","year":"2009","unstructured":"Zhou Q, Zhang B, Verne GN. Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome. Pain. 2009;146(1\u20132):41\u20136.","journal-title":"Pain"},{"key":"888_CR40","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3389\/fimmu.2015.00223","volume":"6","author":"K de Punder","year":"2015","unstructured":"de Punder K, Pruimboom L. Stress induces endotoxemia and low-grade inflammation by increasing barrier permeability. Front Immunol. 2015;6:223.","journal-title":"Front Immunol"},{"issue":"5","key":"888_CR41","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s00421-017-3582-4","volume":"117","author":"DS March","year":"2017","unstructured":"March DS, Marchbank T, Playford RJ, Jones AW, Thatcher R, Davison G. Intestinal fatty acid-binding protein and gut permeability responses to exercise. Eur J Appl Physiol. 2017;117(5):931\u201341.","journal-title":"Eur J Appl Physiol"},{"issue":"2","key":"888_CR42","first-page":"89","volume":"17","author":"A Mulak","year":"2010","unstructured":"Mulak A, Tache Y. Sex difference in irritable bowel syndrome: do gonadal hormones play a role? Gastroenterol Pol. 2010;17(2):89\u201397.","journal-title":"Gastroenterol Pol"},{"issue":"Suppl 2","key":"888_CR43","first-page":"38","volume":"152","author":"A Rubio-Tapia","year":"2016","unstructured":"Rubio-Tapia A, Jansson-Knodell CL, Rahim MW, See JA, Murray JA. Influence of gender on the clinical presentation and associated diseases in adults with celiac disease. Gac Med Mex. 2016;152(Suppl 2):38\u201346.","journal-title":"Gac Med Mex"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-018-0888-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12876-018-0888-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-018-0888-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T19:17:42Z","timestamp":1572981462000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-018-0888-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,6]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["888"],"URL":"https:\/\/doi.org\/10.1186\/s12876-018-0888-6","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.734381887.793570051","asserted-by":"object"}]},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,6]]},"assertion":[{"value":"14 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Institutional Ethics Committee of IRCCS Ospedale Oncologico di Bari - Istituto Tumori Giovanni Paolo II, Bari, Italy, DDG reg. 1227\/2013. The study was part of registered research on\n                      \n                      (reg. Number: NCT01574209). Written informed consent was obtained from all the patients and healthy participants for blood testing and clinical data collection.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"167"}}